Current controversies in prenatal diagnosis 2: Prediction and prevention of adverse pregnancy outcomes requires a genomic rather than proteomic solution

Rossa W K Chiu, Leslie Myatt, Lucas Otaño

Research output: Contribution to journalArticle

Abstract

What's already known about this topic?Adverse pregnancy outcomes associated with placental dysfunction is a leading cause of perinatal morbidity and mortality in the non-malformed fetus/newborn and also of maternal morbidity and mortality.They are also responsible for long-term effects on maternal and child/adult health.They encompass different clinical phenotypes for which the etiopathophysiology is far from being well understood. What does this study add?This study provides a written transcript to accompany an oral debate that was presented at the 18th International Conference on Prenatal Diagnosis and Therapy in Brisbane, Australia, on 22 July 2014.It provides different insights about the potential benefits of different approaches, proteomics, and genomics, in the search for improving our knowledge in placental mediated adverse pregnancy outcomes.

Original languageEnglish (US)
Pages (from-to)15-18
Number of pages4
JournalPrenatal Diagnosis
Volume35
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Pregnancy Outcome
Prenatal Diagnosis
Proteomics
Morbidity
Maternal Mortality
Perinatal Mortality
Genomics
Fetus
Mothers
Phenotype
Therapeutics
Child Health

ASJC Scopus subject areas

  • Genetics(clinical)
  • Obstetrics and Gynecology

Cite this

Current controversies in prenatal diagnosis 2 : Prediction and prevention of adverse pregnancy outcomes requires a genomic rather than proteomic solution. / Chiu, Rossa W K; Myatt, Leslie; Otaño, Lucas.

In: Prenatal Diagnosis, Vol. 35, No. 1, 01.01.2015, p. 15-18.

Research output: Contribution to journalArticle

@article{2806bd4b8934470e903dbab81845214b,
title = "Current controversies in prenatal diagnosis 2: Prediction and prevention of adverse pregnancy outcomes requires a genomic rather than proteomic solution",
abstract = "What's already known about this topic?Adverse pregnancy outcomes associated with placental dysfunction is a leading cause of perinatal morbidity and mortality in the non-malformed fetus/newborn and also of maternal morbidity and mortality.They are also responsible for long-term effects on maternal and child/adult health.They encompass different clinical phenotypes for which the etiopathophysiology is far from being well understood. What does this study add?This study provides a written transcript to accompany an oral debate that was presented at the 18th International Conference on Prenatal Diagnosis and Therapy in Brisbane, Australia, on 22 July 2014.It provides different insights about the potential benefits of different approaches, proteomics, and genomics, in the search for improving our knowledge in placental mediated adverse pregnancy outcomes.",
author = "Chiu, {Rossa W K} and Leslie Myatt and Lucas Ota{\~n}o",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/pd.4533",
language = "English (US)",
volume = "35",
pages = "15--18",
journal = "Prenatal Diagnosis",
issn = "0197-3851",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Current controversies in prenatal diagnosis 2

T2 - Prediction and prevention of adverse pregnancy outcomes requires a genomic rather than proteomic solution

AU - Chiu, Rossa W K

AU - Myatt, Leslie

AU - Otaño, Lucas

PY - 2015/1/1

Y1 - 2015/1/1

N2 - What's already known about this topic?Adverse pregnancy outcomes associated with placental dysfunction is a leading cause of perinatal morbidity and mortality in the non-malformed fetus/newborn and also of maternal morbidity and mortality.They are also responsible for long-term effects on maternal and child/adult health.They encompass different clinical phenotypes for which the etiopathophysiology is far from being well understood. What does this study add?This study provides a written transcript to accompany an oral debate that was presented at the 18th International Conference on Prenatal Diagnosis and Therapy in Brisbane, Australia, on 22 July 2014.It provides different insights about the potential benefits of different approaches, proteomics, and genomics, in the search for improving our knowledge in placental mediated adverse pregnancy outcomes.

AB - What's already known about this topic?Adverse pregnancy outcomes associated with placental dysfunction is a leading cause of perinatal morbidity and mortality in the non-malformed fetus/newborn and also of maternal morbidity and mortality.They are also responsible for long-term effects on maternal and child/adult health.They encompass different clinical phenotypes for which the etiopathophysiology is far from being well understood. What does this study add?This study provides a written transcript to accompany an oral debate that was presented at the 18th International Conference on Prenatal Diagnosis and Therapy in Brisbane, Australia, on 22 July 2014.It provides different insights about the potential benefits of different approaches, proteomics, and genomics, in the search for improving our knowledge in placental mediated adverse pregnancy outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84921508847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921508847&partnerID=8YFLogxK

U2 - 10.1002/pd.4533

DO - 10.1002/pd.4533

M3 - Article

C2 - 25394390

AN - SCOPUS:84921508847

VL - 35

SP - 15

EP - 18

JO - Prenatal Diagnosis

JF - Prenatal Diagnosis

SN - 0197-3851

IS - 1

ER -